Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds. (2934)
Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds. (statistical code 2934): imports in August 2026 were JPY 6,513,953,000 (-24.6% year on year), quantity 1,310,666 KG, unit price JPY 4,956 per KG. Main origins: People's Republic of China (33.1%), India (22.6%), Germany (10.9%), Republic of Korea (9.3%), Switzerland (7.6%). Figures for August 2026 are preliminary.
Exports in the same month were JPY 6,668,503,000, a trade surplus of JPY 154,550,000. (imports: preliminary; exports: revised)
Export statistics for this code
Monthly statistics
| Month | Status | Import value | Quantity | Unit price | Year-on-year |
|---|---|---|---|---|---|
| August 2026 | preliminary | JPY 6,513,953,000 | 1,310,666 | JPY 4,956 | -24.6% |
| July 2026 | revised | JPY 27,211,258,000 | 2,197,624 | JPY 12,376 | +7.1% |
| June 2026 | revised | JPY 9,418,706,000 | 1,563,026 | JPY 6,024 | -1.8% |
| May 2026 | revised | JPY 7,622,308,000 | 1,526,568 | JPY 4,987 | -47.4% |
| April 2026 | revised | JPY 10,928,243,000 | 2,175,003 | JPY 5,010 | +2.7% |
| March 2026 | revised | JPY 12,294,745,000 | 2,122,840 | JPY 5,763 | -20.4% |
| February 2026 | revised | JPY 5,994,848,000 | 1,330,700 | JPY 4,498 | -53.4% |
| January 2026 | revised | JPY 7,533,896,000 | 1,673,364 | JPY 4,497 | -56.0% |
| December 2025 | revised (second) | JPY 24,881,624,000 | 1,255,109 | JPY 19,823 | -1.4% |
| November 2025 | revised (second) | JPY 12,432,111,000 | 1,536,334 | JPY 8,087 | -37.9% |
| October 2025 | revised (second) | JPY 10,951,496,000 | 1,680,327 | JPY 6,505 | -63.8% |
| September 2025 | revised (second) | JPY 10,966,003,000 | 1,859,290 | JPY 5,892 | -8.4% |
| August 2025 | revised (second) | JPY 8,634,376,000 | 1,320,097 | JPY 6,532 | -10.1% |
| July 2025 | revised (second) | JPY 25,401,163,000 | 1,659,152 | JPY 15,299 | +118.2% |
| June 2025 | revised (second) | JPY 9,593,650,000 | 1,578,777 | JPY 6,064 | -51.1% |
| May 2025 | revised (second) | JPY 14,483,938,000 | 1,593,173 | JPY 9,079 | -6.1% |
| April 2025 | revised (second) | JPY 10,645,959,000 | 1,660,857 | JPY 6,392 | -53.3% |
| March 2025 | revised (second) | JPY 15,448,079,000 | 1,600,398 | JPY 9,648 | -3.4% |
| February 2025 | revised (second) | JPY 12,857,482,000 | 1,650,639 | JPY 7,775 | +17.0% |
| January 2025 | revised (second) | JPY 17,107,901,000 | 2,266,259 | JPY 7,540 | +100.9% |
| December 2024 | final | JPY 25,229,261,000 | 2,229,572 | JPY 11,314 | +33.5% |
| November 2024 | final | JPY 20,004,978,000 | 1,634,548 | JPY 12,232 | +29.5% |
| October 2024 | final | JPY 30,274,730,000 | 2,867,696 | JPY 10,537 | +101.9% |
| September 2024 | final | JPY 11,970,938,000 | 1,967,346 | JPY 6,068 | -27.3% |
Subcategories
- Compounds containing an unfused thiazole ring (whether or not hydrogenated) in the structure
- Compounds containing in the structure a benzothiazole ring-system (whether or not hydrogenated), not further fused
- Compounds containing in the structure a phenothiazine ring-system (whether or not hydrogenated), not further fused
- Aminorex (INN), brotizolam (INN), clotiazepam (INN), cloxazolam (INN), dextromoramide (INN), haloxazolam (INN), ketazolam (INN), mesocarb (INN), oxazolam (INN), pemoline (INN), phendimetrazine (INN), phenmetrazine (INN) and sufentanil (INN); salts thereof
- 1 Sultones and sultams
- Acesulfame potassium (INN)
- Lithium bis (oxalate) borate
- Other
API and MCP
No API key required. An optional API key gives you a dedicated quota of 1,000 requests per day that is not affected by congestion (free at https://data.washutrading.com/register/).
Example API request for this item: https://data.washutrading.com/api/v1/series?code=2934&flow=import